Related Experiment Video
Updated: May 10, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Leishmaniasis: clinical syndromes and treatment
1Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University, Doan N1145, 410 W. 10th Ave., Columbus, OH 43210, USA. brad.mcgwire@osumc.edu.
Abstract:
Leishmaniasis is a global term for cutaneous and visceral anthroponotic and zoonotic diseases caused by the vector-borne parasites of the genus Leishmania. These diseases afflict at least 2 million people each year with more than 350 million at risk in 98 countries worldwide. These are diseases mostly of the impoverished making prevention, diagnosis and treatment difficult. Therapy of leishmaniasis ranges from local treatment of cutaneous lesions to systemic, often toxic, therapy for disseminated cutaneous, mucocutaneous and deadly visceral disease. This review is a summary of the clinical syndromes caused by Leishmania and treatment regimens currently used for various forms of leishmaniasis.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Fungal Phylum Microsporidia
Nephrotic Syndrome II : Assessment and Medical Management
Sexually Transmitted Infections
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Anthelminthic Agents

